Inquiry Basket
Loading ......
Filter By Product Search for
IL-1R
IL-1R Full Name
Interleukin-1 receptor
IL-1R Introduction
Interleukin-1 receptor (IL-1R) is a key component of the innate immune signaling network that mediates the biological effects of interleukin-1 cytokines, particularly IL-1α and IL-1β. As part of the IL-1 receptor family, the most extensively studied signaling receptor is IL-1R1, which forms a functional signaling complex with the IL-1 receptor accessory protein (IL-1RAP). Upon ligand binding, this receptor complex initiates intracellular signaling through the conserved Toll/Interleukin-1 receptor (TIR) domain. Activation of the TIR domain recruits adaptor proteins such as MyD88, leading to downstream activation of NF-κB and MAPK signaling pathways. These pathways regulate the expression of pro-inflammatory genes, cytokines, and chemokines that are essential for host defense and immune coordination. Because IL-1R signaling acts as an early alarm system for infection and tissue damage, dysregulation of this pathway often results in excessive inflammation, making IL-1R a critical molecular target in immunology and inflammatory disease research.
Growing genetic and molecular evidence highlights the central role of IL-1R family members in a wide spectrum of immune-mediated and inflammatory disorders. A comprehensive review published in Biomed Research International (2023) summarized genetic studies showing that polymorphisms in IL-1R-related genes, including IL-1R1, IL-1R2, and IL-1RAP, are associated with susceptibility to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. These findings reinforce the importance of IL-1R signaling in shaping inflammatory responses and maintaining immune balance. Importantly, MyD88-dependent signaling downstream of IL-1R functions as a central hub controlling cytokine production and immune cell activation. Variations in these signaling components can alter immune responses, leading to chronic inflammation or impaired host defense. As a result, IL-1R-related pathways are increasingly investigated as predictive biomarkers and therapeutic targets for immune disorders where precise modulation of inflammation is required.
Beyond classical inflammatory diseases, IL-1R signaling has also been implicated in cancer biology and degenerative musculoskeletal disorders. Chronic activation of IL-1R-mediated inflammatory pathways can contribute to tumor initiation and progression by remodeling the tumor microenvironment and promoting immune cell recruitment, angiogenesis, and cancer cell survival. Studies exploring IL-1R/TLR signaling pathways have shown that persistent inflammatory signaling may serve as a driving force behind the development of inflammation-associated cancers such as colorectal cancer. In orthopedic research, mechanical stress has been shown to significantly increase IL-1R expression in cartilage cells, enhancing their sensitivity to IL-1-induced inflammatory signaling. This heightened responsiveness leads to elevated production of matrix metalloproteinases (MMPs), accelerating cartilage matrix degradation and contributing to the progression of osteoarthritis. These findings highlight why IL-1R is widely investigated as a potential therapeutic target in oncology, inflammatory diseases, and degenerative joint disorders, as blocking IL-1R signaling may help mitigate chronic inflammation and tissue damage while improving disease outcomes.
Alternate Names for IL-1R
Antigen CD121a; CD121 antigen-like family member A; CD121A; CD121a antigen; D2S1473; IL 1; IL 1R alpha; IL1 inhibitor; IL1R; IL1R1_HUMAN
Loading ......
